General American Investors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $24.6M | Hold |
204,326
| – | – | 1.62% | 20 |
|
|
2025
Q4 | $21.5M | Hold |
204,326
| – | – | 1.21% | 24 |
|
|
2025
Q3 | $17.1M | Hold |
204,326
| – | – | 0.99% | 35 |
|
|
2025
Q2 | $16.2M | Hold |
204,326
| – | – | 1.04% | 35 |
|
|
2025
Q1 | $18.3M | Hold |
204,326
| – | – | 1.34% | 24 |
|
|
2024
Q4 | $20.3M | Hold |
204,326
| – | – | 1.41% | 23 |
|
|
2024
Q3 | $23.2M | Hold |
204,326
| – | – | 1.6% | 20 |
|
|
2024
Q2 | $25.3M | Hold |
204,326
| – | – | 1.76% | 15 |
|
|
2024
Q1 | $27M | Hold |
204,326
| – | – | 1.93% | 15 |
|
|
2023
Q4 | $22.3M | Buy |
204,326
+25,000
| +14% | +$2.6M | 1.76% | 17 |
|
|
2023
Q3 | $18.5M | Hold |
179,326
| – | – | 1.65% | 17 |
|
|
2023
Q2 | $20.7M | Hold |
179,326
| – | – | 1.8% | 18 |
|
|
2023
Q1 | $19.1M | Hold |
179,326
| – | – | 1.81% | 18 |
|
|
2022
Q4 | $19.9M | Sell |
179,326
-60,865
| -25% | -$6.22M | 1.95% | 17 |
|
|
2022
Q3 | $20.7M | Hold |
240,191
| – | – | 2.15% | 14 |
|
|
2022
Q2 | $21.9M | Hold |
240,191
| – | – | 2.2% | 15 |
|
|
2022
Q1 | $19.7M | Hold |
240,191
| – | – | 1.61% | 19 |
|
|
2021
Q4 | $18.4M | Sell |
240,191
-15,000
| -6% | -$1.19M | 1.44% | 23 |
|
|
2021
Q3 | $19.2M | Buy |
255,191
+10,000
| +4% | +$761K | 1.63% | 19 |
|
|
2021
Q2 | $19.1M | Sell |
245,191
-11,769
| -5% | -$875K | 1.6% | 18 |
|
|
2021
Q1 | $18.9M | Hold |
256,960
| – | – | 1.77% | 20 |
|
|
2020
Q4 | $20.1M | Hold |
256,960
| – | – | 1.98% | 17 |
|
|
2020
Q3 | $20.3M | Buy |
256,960
+47,160
| +22% | +$3.69M | 2.35% | 15 |
|
|
2020
Q2 | $15.5M | Buy |
209,800
+15,720
| +8% | +$1.18M | 1.96% | 17 |
|
|
2020
Q1 | $14.2M | Hold |
194,080
| – | – | 1.93% | 18 |
|
|
2019
Q4 | $16.8M | Hold |
194,080
| – | – | 1.54% | 25 |
|
|
2019
Q3 | $15.6M | Hold |
194,080
| – | – | 1.54% | 24 |
|
|
2019
Q2 | $15.5M | Hold |
194,080
| – | – | 1.47% | 28 |
|
|
2019
Q1 | $15.4M | Sell |
194,080
-15,720
| -7% | -$1.18M | 1.53% | 26 |
|
|
2018
Q4 | $15.3M | Hold |
209,800
| – | – | 1.61% | 21 |
|
|
2018
Q3 | $14.2M | Hold |
209,800
| – | – | 1.22% | 36 |
|
|
2018
Q2 | $12.2M | Hold |
209,800
| – | – | 1.11% | 40 |
|
|
2018
Q1 | $10.9M | Hold |
209,800
| – | – | 1.03% | 40 |
|
|
2017
Q4 | $11.3M | Hold |
209,800
| – | – | 1.09% | 38 |
|
|
2017
Q3 | $12.8M | Sell |
209,800
-31,440
| -13% | -$1.91M | 1.22% | 38 |
|
|
2017
Q2 | $14.8M | Sell |
241,240
-36,680
| -13% | -$2.23M | 1.49% | 34 |
|
|
2017
Q1 | $16.9M | Hold |
277,920
| – | – | 1.65% | 29 |
|
|
2016
Q4 | $15.6M | Sell |
277,920
-138,336
| -33% | -$8.1M | 1.58% | 27 |
|
|
2016
Q3 | $24.8M | Sell |
416,256
-31,440
| -7% | -$1.84M | 2.53% | 10 |
|
|
2016
Q2 | $24.6M | Hold |
447,696
| – | – | 2.56% | 11 |
|
|
2016
Q1 | $22.6M | Hold |
447,696
| – | – | 2.34% | 15 |
|
|
2015
Q4 | $22.6M | Hold |
447,696
| – | – | 2.07% | 16 |
|
|
2015
Q3 | $21.1M | Hold |
447,696
| – | – | 1.9% | 20 |
|
|
2015
Q2 | $24.3M | Hold |
447,696
| – | – | 2% | 19 |
|
|
2015
Q1 | $24.6M | Hold |
447,696
| – | – | 2.02% | 19 |
|
|
2014
Q4 | $24.3M | Hold |
447,696
| – | – | 1.94% | 20 |
|
|
2014
Q3 | $25.3M | Hold |
447,696
| – | – | 2.02% | 19 |
|
|
2014
Q2 | $24.7M | Hold |
447,696
| – | – | 2.01% | 19 |
|
|
2014
Q1 | $24.3M | Hold |
447,696
| – | – | 2.03% | 20 |
|
|
2013
Q4 | $21.4M | Buy |
447,696
+107,096
| +31% | +$4.9M | 1.74% | 25 |
|
|
2013
Q3 | $15.5M | Hold |
340,600
| – | – | 1.35% | 35 |
|
|
2013
Q2 | $15.1M | Buy |
+340,600
| New | +$15.2M | 1.37% | 32 |
|
Other funds holding MRK
VCM
VPM
General American Investors's MRK Position: Q1 2026 in Review
General American Investors held its Merck (MRK) position steady in Q1 2026 at 204,326 shares worth $24.6M. The position accounts for 1.62% of the portfolio, ranked #20.
General American Investors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- General American Investors held 204,326 shares of Merck worth $24.6M as of Q1 2026.
- General American Investors left its Merck share count unchanged in Q1 2026.
- Merck made up 1.62% of General American Investors's portfolio in Q1 2026, its #20 holding.
- General American Investors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- General American Investors's Merck position peaked at $27M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on General American Investors's 13F filing for Q1 2026, filed 1 May 2026.